View Clinical Trial (Medical Research Study)


A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience - NCT01043185-(Clinical Trial 464163)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup

City:  Oklahoma City
State:  
OK
Zip Code:
Conditions: Gastroesophageal Reflux Disease
Purpose: The purpose of the study is to estimate what effect 4 different doses of lesogaberan (AZD3355) will have on the number of reflux episodes, in patients who have GERD and still experience symptoms despite proton pump inhibitor (PPI) treatment.
Study summary:
Criteria: Inclusion Criteria: - Provide informed consent - History of GERD with persistent symptoms despite treatment with PPI - Otherwise normal physical health Exclusion Criteria: - History of GERD with symptoms that has not improved at all during treatment with PPI - Prior surgery of the upper gastrointestinal tract - History of significant heart disease, cardiovascular, respiratory, hepatic, renal, metabolic, psychiatric or gastrointestinal disorders besides GERD
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source: ClinicalTrials.gov
Date Processed: May 21, 2010
Modifications to
this listing:
Only selected fields are shown, please use the link above to view all information about this clinical trial.